{"entity":{"type":"insider","cik":"0001665124","url":"/insider/0001665124","json_url":"/insider/0001665124.json","name":"Nagendran Sukumar","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":21,"first":"2017-04-05","last":"2026-07-10","span_basis":"filed_date"},"name_variants":[{"name":"Nagendran Sukumar","source":"filing","n_filings":21,"first_seen":"2017-04-05","last_seen":"2026-07-10"}],"transactions":[{"id":5922566,"accession":"0001665124-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001665124-26-000013","line_url":"/filing/0001665124-26-000013#line-1","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":6.24,"price_display":"6.24","price_state":"stated","total_value":1248000.0,"total_display":"1,248,000.00","total_whole":"1,248,000","shares_owned_after":936410.0,"shares_owned_after_display":"936,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-10","filed_date":"2026-07-10","scope":"insider"},{"id":6003042,"accession":"0001665124-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001665124-26-000011","line_url":"/filing/0001665124-26-000011#line-2","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":4.46,"price_display":"4.46","price_state":"stated","total_value":892000.0,"total_display":"892,000.00","total_whole":"892,000","shares_owned_after":1136410.0,"shares_owned_after_display":"1,136,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-10","filed_date":"2026-04-13","scope":"insider"},{"id":6220859,"accession":"0001665124-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001665124-26-000008","line_url":"/filing/0001665124-26-000008#line-2","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26918.0,"shares_display":"26,918","price_per_share":4.61,"price_display":"4.61","price_state":"stated","total_value":124091.98,"total_display":"124,091.98","total_whole":"124,092","shares_owned_after":1317389.0,"shares_owned_after_display":"1,317,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-27","scope":"insider"},{"id":6220852,"accession":"0001665124-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001665124-26-000008","line_url":"/filing/0001665124-26-000008#line-1","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89132.0,"shares_display":"89,132","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":423377.0,"total_display":"423,377.00","total_whole":"423,377","shares_owned_after":1344307.0,"shares_owned_after_display":"1,344,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-01-27","scope":"insider"},{"id":6198192,"accession":"0001665124-26-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001665124-26-000002","line_url":"/filing/0001665124-26-000002#line-4","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":942000.0,"total_display":"942,000.00","total_whole":"942,000","shares_owned_after":1006439.0,"shares_owned_after_display":"1,006,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":5175620,"accession":"0001665124-25-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001665124-25-000003","line_url":"/filing/0001665124-25-000003#line-5","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260047.0,"shares_display":"260,047","price_per_share":4.51,"price_display":"4.51","price_state":"stated","total_value":1172811.97,"total_display":"1,172,811.97","total_whole":"1,172,812","shares_owned_after":1006439.0,"shares_owned_after_display":"1,006,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-01","scope":"insider"},{"id":5175612,"accession":"0001665124-25-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001665124-25-000003","line_url":"/filing/0001665124-25-000003#line-3","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110125.0,"shares_display":"110,125","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":523093.75,"total_display":"523,093.75","total_whole":"523,094","shares_owned_after":1006439.0,"shares_owned_after_display":"1,006,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-28","filed_date":"2025-12-01","scope":"insider"},{"id":4709382,"accession":"0001415889-25-024369","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-024369","line_url":"/filing/0001415889-25-024369#line-2","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":3.23,"price_display":"3.23","price_state":"stated","total_value":646000.0,"total_display":"646,000.00","total_whole":"646,000","shares_owned_after":1006439.0,"shares_owned_after_display":"1,006,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-12","scope":"insider"},{"id":4953268,"accession":"0001415889-25-022750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022750","line_url":"/filing/0001415889-25-022750#line-1","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57054.0,"shares_display":"57,054","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":162603.9,"total_display":"162,603.90","total_whole":"162,604","shares_owned_after":1165289.0,"shares_owned_after_display":"1,165,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":7815071,"accession":"0001209191-23-030661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030661","line_url":"/filing/0001209191-23-030661#line-1","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director, Officer (President and Head of R&D)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Head of R&D","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":3400.0,"total_display":"3,400.00","total_whole":"3,400","shares_owned_after":34226.0,"shares_owned_after_display":"34,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":6776984,"accession":"0001209191-22-006652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-006652","line_url":"/filing/0001209191-22-006652#line-1","is_derivative":false,"issuer_cik":"0001665124","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001665124","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":80100.0,"total_display":"80,100.00","total_whole":"80,100","shares_owned_after":29226.0,"shares_owned_after_display":"29,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider"},{"id":6902673,"accession":"0001209191-18-016481","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-016481","line_url":"/filing/0001209191-18-016481","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":126.18999438202248,"price_display":"126.19","price_state":"stated","total_value":224618.19,"total_display":"224,618.19","total_whole":"224,618","shares_owned_after":458.0,"shares_owned_after_display":"458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider","n_lines":7},{"id":6631012,"accession":"0001209191-18-007554","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-007554","line_url":"/filing/0001209191-18-007554","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":117.9600786516854,"price_display":"117.96","price_state":"stated","total_value":209968.94,"total_display":"209,968.94","total_whole":"209,969","shares_owned_after":779.0,"shares_owned_after_display":"779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider","n_lines":5},{"id":6074906,"accession":"0001209191-18-002110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-002110","line_url":"/filing/0001209191-18-002110","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":109.72357303370786,"price_display":"109.72","price_state":"stated","total_value":195307.96,"total_display":"195,307.96","total_whole":"195,308","shares_owned_after":684.0,"shares_owned_after_display":"684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider","n_lines":2},{"id":4997919,"accession":"0001209191-17-064044","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-064044","line_url":"/filing/0001209191-17-064044","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":94.77311797752809,"price_display":"94.77","price_state":"stated","total_value":168696.15,"total_display":"168,696.15","total_whole":"168,696","shares_owned_after":135.0,"shares_owned_after_display":"135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider","n_lines":3},{"id":4997065,"accession":"0001209191-17-059215","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-059215","line_url":"/filing/0001209191-17-059215","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":101.2606797752809,"price_display":"101.26","price_state":"stated","total_value":180244.01,"total_display":"180,244.01","total_whole":"180,244","shares_owned_after":466.0,"shares_owned_after_display":"466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-03","scope":"insider","n_lines":7},{"id":5255011,"accession":"0001209191-17-055231","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-055231","line_url":"/filing/0001209191-17-055231","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":97.25157865168539,"price_display":"97.25","price_state":"stated","total_value":173107.81,"total_display":"173,107.81","total_whole":"173,108","shares_owned_after":1142.0,"shares_owned_after_display":"1,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-03","scope":"insider","n_lines":4},{"id":4268089,"accession":"0001209191-17-051431","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-051431","line_url":"/filing/0001209191-17-051431","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":93.24602247191011,"price_display":"93.25","price_state":"stated","total_value":165977.92,"total_display":"165,977.92","total_whole":"165,978","shares_owned_after":574.0,"shares_owned_after_display":"574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-05","scope":"insider","n_lines":2},{"id":4359079,"accession":"0001209191-17-047420","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-047420","line_url":"/filing/0001209191-17-047420","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":91.52030898876404,"price_display":"91.52","price_state":"stated","total_value":162906.15,"total_display":"162,906.15","total_whole":"162,906","shares_owned_after":713.0,"shares_owned_after_display":"713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-01","filed_date":"2017-08-03","scope":"insider","n_lines":3},{"id":5352221,"accession":"0001209191-17-043569","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-043569","line_url":"/filing/0001209191-17-043569","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":81.88062921348315,"price_display":"81.88","price_state":"stated","total_value":145747.52,"total_display":"145,747.52","total_whole":"145,748","shares_owned_after":299.0,"shares_owned_after_display":"299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-05","scope":"insider","n_lines":2},{"id":4783423,"accession":"0001209191-17-037268","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-037268","line_url":"/filing/0001209191-17-037268","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":70.906702247191,"price_display":"70.91","price_state":"stated","total_value":126213.93,"total_display":"126,213.93","total_whole":"126,214","shares_owned_after":170.0,"shares_owned_after_display":"170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-02","scope":"insider","n_lines":3},{"id":5173378,"accession":"0001209191-17-029252","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-029252","line_url":"/filing/0001209191-17-029252#line-4","is_derivative":false,"issuer_cik":"0001652923","issuer_name":"AveXis, Inc.","issuer_ticker":"AVXS","issuer_name_source":null,"issuer_url":"/issuer/0001652923","owner_cik":"0001665124","owner_name":"Nagendran Sukumar","owner_display_name":"Nagendran Sukumar","owner_url":"/insider/0001665124","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1182.0,"shares_display":"1,182","price_per_share":81.11,"price_display":"81.11","price_state":"stated","total_value":95872.02,"total_display":"95,872.02","total_whole":"95,872","shares_owned_after":598.0,"shares_owned_after_display":"598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-02","scope":"insider"}],"collapsed":true,"next_cursor":"2017-05-01|5173378","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806310","name":"Taysha Gene Therapies, Inc.","url":"/issuer/0001806310","role":"Director, Officer (President and Head of R&D)","n_filings":9,"first_seen":"2022-02-03","last_seen":"2026-07-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001652923","name":"AveXis, Inc.","url":"/issuer/0001652923","role":"Officer (Sr. VP & Chief Medical Officer)","n_filings":12,"first_seen":"2017-04-05","last_seen":"2018-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001665124","retrieved_at":"2026-08-24T07:48:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}